Social Anxiety DisorderOASISNCT06673407
Group Exposure Workshops for Socially Anxious Undergraduates
A study testing Group Exposure for Social Anxiety, Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety and Peer-Enhanced Group Exposure Therapy for Social Anxiety in people with Social Anxiety Disorder and Public Speaking Fear, run by University of Colorado, Boulder at 1 site in United States.
Trial summary
The purpose of the study is to investigate the effects of four versions of a workshop for social anxiety and public speaking stress. All participants are current University of Colorado Boulder undergraduate students. Read more about this study
- Who is it for?
- Ages 18 to 30 years
- Conditions the study is for
- Social Anxiety Disorder, Public Speaking Fear, Public Speaking Anxiety
- What is being tested?
- Group Exposure for Social Anxiety, Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety and Peer-Enhanced Group Exposure Therapy for Social Anxiety
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 200 participants
- Where
- 1 siteUnited States
- Study dates
- 12 Jun 2024to 1 Oct 2025
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- All sexes
- No healthy volunteers
- Adult
Who may be able to join
- Age = 18-30
- Able to read and write fluently in English
- Current undergraduate students at CU
- Experiencing elevated social anxiety symptoms indicated by a SPIN score ≥ 19
- Experiencing moderate to high communication anxiety indicated by a PRCA- 24 score ≥ 59
- Open to receiving help for social anxiety or public speaking fears indicated by a help seeking score of ≥ 3 out of 5 (at both screening timepoints as explained below)
- Able to voluntarily consent to participation
- Able to participate fully in the study (including in the in-person group workshops and in survey completion) as assessed by screening questions and the study P
Who cannot join
- Are currently experiencing moderately severe or severe depression represented by the validated cutoff score for major depression on the PHQ-8 of greater than 14 (Kroenke et al., 2001)
- Score in the moderate-high range for suicide risk as indicated by the CSSRS (Salvi, 2019), report a suicide attempt in the past 12 months, or report current, ongoing suicidal ideation along with a past (lifetime) suicide attempt
- Are current students of the PI or clients or current students of the doctoral student co-facilitators
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
United States1 site, 1 recruiting
- Recruiting
Renee Crown Wellness Institute and Department of Psychology & Neuroscience, University of Colorado Boulder
Boulder, Colorado, 80302
Joanna Arch, PhD, 303.492.4634, joanna.arch@colorado.edu
Joanna Arch, PhD
About this study
Official title: Pilot Trial on the Contribution of Peer Leaders and Self-Compassion to Group Exposure Workshops for Socially Anxious Undergraduates
The purpose of the study is to investigate the effects of four versions of a workshop for social anxiety and public speaking stress. All participants are current University of Colorado Boulder undergraduate students. Participation in this research study lasts for approximately 8 weeks, and includes a pre-workshop questionnaire, 3 weekly workshop sessions (ranging from 2 to 3 hours each, including a 5-minute post-session questionnaire), a post-workshop questionnaire, and a 1-month follow-up questionnaire.
Read the detailed description
The present study seeks to evaluate the feasibility, acceptability, and efficacy potential of a full factorial trial of a peer-led common humanity- and exposure-based workshop for social anxiety within a Multiphase Optimization Strategy (MOST) trial framework. The present study seeks to enroll and randomize participants (up to N = 200) by cohort to one of four conditions, reflecting a full factorial trial design. The inclusion of common humanity enhancements and the presence of a peer leader will each serve as independent variables, comprising of the following four study conditions: 1) common humanity with peer leader, 2) common humanity without peer leader, 3) peer leader without common humanity, and 4) exposure only (no common humanity and no peer leader). The investigators will assess outcomes after the workshop sessions (mid1, mid2, mid3, Post[T1]) and one-month following the conclusion of the last workshop session (T2).
The study has the following aims and hypotheses:
Aim 1: To evaluate the feasibility and acceptability of conducting a full factorial trial of a group exposure workshop for social anxiety within a MOST trial framework.
Hypothesis 1a (feasibility): At least 50% of screened, eligible participants will enroll in the study.
Hypothesis 1b (feasibility): Enrolled research participants will attend on average at least 2 out of 3 workshop sessions.
Hypothesis 1c (feasibility): Workshops will be delivered with high fidelity (80% of content checklist items covered, on average) and low contamination (20% or less inclusion of content specific to other conditions, on average) in each randomized condition.
Hypothesis 1d (acceptability): Participants will report a median satisfaction with the workshops of 4 or higher on the 1-5 Acceptability of Intervention Measure (AIM).
Hypothesis 1e (acceptability): Participation in the group workshops will be acceptable, indicated by high overall satisfaction with the workshop across conditions (mean rating of >20 on the Client Satisfaction Questionnaire-8).
Hypothesis 1f (acceptability): ≤20% of participants will report a study burden of 4 or higher on a 1-5 burden measure.
Aim 2: To evaluate the feasibility and efficacy potential of primary and secondary outcomes. Please note that the investigators do not expect to find statistically significant differences between conditions in this pilot study - only patterns of differences in the predicted directions outlined below. This pilot study will establish the foundation for a larger, definitively powered, future trial.
Hypothesis 2a (Feasibility of assessment): At least 70% of participants will complete pre, post, and follow-up surveys.
Hypothesis 2b (Efficacy potential): Compared to the exposure only condition, reliable change magnitudes (Jacobson \& Truax, 1991) will be higher within the peer and compassion-enhanced conditions, with additive effects for the fully enhanced condition, on measures of 1) participant retention, 2) social anxiety, 3) depression, and 4) self-compassion.
Hypothesis 2c (Cultivating community): Compared to the exposure-only condition, reliable change magnitudes will be higher within the peer and compassion-enhanced conditions, with additive effects for the fully enhanced condition, on measures of 1) stigma and 2) sense of belonging.
Hypothesis 2d (Barriers to access and engagement): Compared to the exposure only condition, reliable change magnitudes will be higher in the peer and compassion-enhanced conditions, with additive effects for the fully enhanced condition, on measures of 1) enjoyableness, 2) likelihood to recommend, and 3) readiness and willingness to engage in therapy. Across conditions, participants will indicate a preference for peer co-facilitators over mental health providers only.
- Being tested
- Group Exposure for Social Anxiety, Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety, Peer-Enhanced Group Exposure Therapy for Social Anxiety, Peer and Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety
- Keywords
- Social Anxiety, Public Speaking Anxiety, Exposure Therapy, Peer-led, Self-compassion, Common Humanity
- Medical subject headings
- Phobia, Social, Glossophobia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Group Exposure for Social AnxietyBehavioural
Group exposure therapy for social anxiety and public speaking fears.
Self-Compassion Enhanced Group Exposure Therapy for Social AnxietyBehavioural
Group exposure therapy for social anxiety and public speaking fears plus piloted exercises from the investigators' previous studies among socially anxious undergraduates (Slivjak et al., 2022; Slivjak \& Arch, in preparation), refined during the investigators' quality improvement project, that are designed to enhance compassion.
Peer-Enhanced Group Exposure Therapy for Social AnxietyBehavioural
Group exposure therapy for social anxiety and public speaking fears facilitated by a pair of doctoral student and undergraduate student co-facilitators who explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears.
Peer and Self-Compassion Enhanced Group Exposure Therapy for Social AnxietyBehavioural
Group exposure therapy for social anxiety and public speaking fears plus piloted exercises from the investigators' previous studies among socially anxious undergraduates (Slivjak et al., 2022; Slivjak \& Arch, in preparation), refined during the investigators' quality improvement project, that are designed to enhance compassion. These groups are facilitated by a pair of doctoral student and undergraduate student co-facilitators who explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears.
| Study group | Role | What they receive |
|---|---|---|
| Exposure Only | Active comparator | Group exposure therapy for social anxiety and public speaking fears. Receives: Behavioral: Group Exposure for Social Anxiety |
| Compassion Enhanced | Experimental | Group exposure therapy for social anxiety and public speaking fears plus self-compassion exercises aimed at inducing a sense of common humanity. Receives: Behavioral: Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety |
| Peer enhanced | Experimental | Group exposure therapy for social anxiety and public speaking fears facilitated by a pair of doctoral student and undergraduate student co-facilitators who will explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears. Receives: Behavioral: Peer-Enhanced Group Exposure Therapy for Social Anxiety |
| Fully enhanced | Experimental | Group exposure therapy for social anxiety and public speaking fears plus self-compassion exercises aimed at inducing a sense of common humanity, facilitated by a pair of doctoral student and undergraduate student co-facilitators who will explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears. Receives: Behavioral: Peer and Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety |
What is being measured
The primary outcome is the main question the study is designed to answer.
Attendance rate
Average number of workshop sessions attended by enrolled research participants.
Measured: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Enrollment rate
Ratio of screened, eligible participants who enrolled in the study.
Measured: Pre-intervention (from screening to enrollment)
Acceptability of Intervention Measure (AIM)
Workshop satisfaction rating, Range = 1 - 5, Higher scores indicate better outcome (greater acceptability)
Measured: 48 hours after the final intervention session and 1-month follow-up
Client Satisfaction Questionnaire-8 (CSQ-8)
Satisfaction with workshops, Range = 8 - 32, Higher scores indicate better outcome (greater satisfaction)
Measured: 48 hours after the final intervention session and 1-month follow-up
Social Phobia Inventory (SPIN)
Social anxiety symptom measure, Range = 0 - 68, Higher scores indicate worse outcome (worse social phobia)
Measured: 48 hours after the final intervention session and 1-month follow-up
Liebowitz Social Anxiety Scale (LSAS)
Measure assessing fear/anxiety across a broad range of social and performance situations, Range = 0 - 144, Higher scores indicate worse outcome (worse social anxiety)
Measured: 48 hours after the final intervention session and 1-month follow-up
Secondary outcomes (13)
Personal Report of Communication Apprehension (PRCA-24)
Measure of trait communication and public speaking anxiety, Range = 24 - 120, Higher scores indicate worse outcome (greater communication apprehension)
Measured: 48 hours after the final intervention session and 1-month follow-up
Fidelity
Percentage of content checklist items covered during in-person workshops.
Measured: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Contamination
Percentage of content specific to other conditions covered in each randomized condition.
Measured: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Study Burden
Rating of study burden.
Measured: 48 hours after the final intervention session and 1-month follow-up
Survey Completion
Percentage of participants who complete pre, post, and follow-up surveys.
Measured: between 10 and 0 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up
Participant Retention
Percentage of participants who completed workshops.
Measured: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Patient Health Questionnaire-8 (PHQ-8)
Measure of depressive symptoms, Range = 0 - 24, Higher scores indicate worse outcome (worse depression)
Measured: 48 hours after the final intervention session and 1-month follow-up
Self-Compassion Scale - Short (SCS)
Measure of trait self-compassion and common humanity, Range = 1 - 5, Higher scores indicate better outcome (greater self-compassion)
Measured: 48 hours after the final intervention session and 1-month follow-up
Stigma and Self-Stigma Scale, help seeking behaviors and self-stigma subscales (SASS)
Measure of stigma toward mental health problems.
Help-seeking behaviors subscale: Range = 0 - 24, Higher scores indicate worse outcome (worse help-seeking behaviors)
Self-stigma subscale: Range = 0 - 24, Higher scores indicate worse outcome (greater self-stigma)
Measured: 48 hours after the final intervention session and 1-month follow-up
Sense of Belonging Scale
Measure of how connected participants feel to their group members, Range = 1-7, Higher = Higher scores indicate better outcome (greater sense of belonging)
Measured: 48 hours after the final intervention session and 1-month follow-up
Likelihood to Recommend
Rating of how likely participants would be to recommend the workshop to others.
Measured: 48 hours after the final intervention session and 1-month follow-up
Enjoyableness
Rating of degree to which participants found the workshop to be enjoyable.
Measured: 48 hours after the final intervention session and 1-month follow-up
Provider preference
Rating of whether participants have a preference for peer co-facilitators over mental health providers only.
Measured: between 0 and 10 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted4 Nov 2024
- Study start12 Jun 2024
- Primary completion1 Oct 2025 (estimated)
- Study completion1 Oct 2025 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Social Anxiety DisorderStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Model description
- This trial uses a 2-variable full factorial design within the Multiphase Optimization Strategy (MOST) framework. Participants will be assigned to one of four study conditions involving 5.5-7.5-hours of workshops (depending on study condition) conducted over 3 in-person group sessions. Study conditions will vary depending on whether they 1) include self-compassion (i.e., common humanity) enhancements, and 2) are led by peer co-facilitators.
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 200 participants (estimated)
Sponsor and investigators
- Lead sponsor
- University of Colorado, Boulder
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Joanna Arch, University of Colorado, Boulder
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06673407
- Sponsor's protocol ID
- 24-0178
- Acronym
- OASIS
- Status last verified
- May 2025
- First submitted
- 8 Oct 2024
- Last updated
- 20 May 2025
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 20 May 2025. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pilot Trial on the Contribution of Peer Leaders and Self-Compassion to Group Exposure Workshops for Socially Anxious Undergraduates
- ClinicalTrials.gov ID
- NCT06673407
- Acronym / sponsor ID
- OASIS / 24-0178
- Keywords
- Social Anxiety, Public Speaking Anxiety, Exposure Therapy, Peer-led, Self-compassion, Common Humanity
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 200 participants (estimated)
- Lead sponsor
- University of Colorado, BoulderUniversity, hospital or other
- Study start
- 12 Jun 2024 (actual)
- Primary completion
- 1 Oct 2025 (estimated)
- Study completion
- 1 Oct 2025 (estimated)
- First posted
- 4 Nov 2024 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the study is to investigate the effects of four versions of a workshop for social anxiety and public speaking stress. All participants are current University of Colorado Boulder undergraduate students. Participation in this research study lasts for approximately 8 weeks, and includes a pre-workshop questionnaire, 3 weekly workshop sessions (ranging from 2 to 3 hours each, including a 5-minute post-session questionnaire), a post-workshop questionnaire, and a 1-month follow-up questionnaire.
Detailed description
The present study seeks to evaluate the feasibility, acceptability, and efficacy potential of a full factorial trial of a peer-led common humanity- and exposure-based workshop for social anxiety within a Multiphase Optimization Strategy (MOST) trial framework. The present study seeks to enroll and randomize participants (up to N = 200) by cohort to one of four conditions, reflecting a full factorial trial design. The inclusion of common humanity enhancements and the presence of a peer leader will each serve as independent variables, comprising of the following four study conditions: 1) common humanity with peer leader, 2) common humanity without peer leader, 3) peer leader without common humanity, and 4) exposure only (no common humanity and no peer leader). The investigators will assess outcomes after the workshop sessions (mid1, mid2, mid3, Post[T1]) and one-month following the conclusion of the last workshop session (T2).
The study has the following aims and hypotheses:
Aim 1: To evaluate the feasibility and acceptability of conducting a full factorial trial of a group exposure workshop for social anxiety within a MOST trial framework.
Hypothesis 1a (feasibility): At least 50% of screened, eligible participants will enroll in the study.
Hypothesis 1b (feasibility): Enrolled research participants will attend on average at least 2 out of 3 workshop sessions.
Hypothesis 1c (feasibility): Workshops will be delivered with high fidelity (80% of content checklist items covered, on average) and low contamination (20% or less inclusion of content specific to other conditions, on average) in each randomized condition.
Hypothesis 1d (acceptability): Participants will report a median satisfaction with the workshops of 4 or higher on the 1-5 Acceptability of Intervention Measure (AIM).
Hypothesis 1e (acceptability): Participation in the group workshops will be acceptable, indicated by high overall satisfaction with the workshop across conditions (mean rating of >20 on the Client Satisfaction Questionnaire-8).
Hypothesis 1f (acceptability): ≤20% of participants will report a study burden of 4 or higher on a 1-5 burden measure.
Aim 2: To evaluate the feasibility and efficacy potential of primary and secondary outcomes. Please note that the investigators do not expect to find statistically significant differences between conditions in this pilot study - only patterns of differences in the predicted directions outlined below. This pilot study will establish the foundation for a larger, definitively powered, future trial.
Hypothesis 2a (Feasibility of assessment): At least 70% of participants will complete pre, post, and follow-up surveys.
Hypothesis 2b (Efficacy potential): Compared to the exposure only condition, reliable change magnitudes (Jacobson \& Truax, 1991) will be higher within the peer and compassion-enhanced conditions, with additive effects for the fully enhanced condition, on measures of 1) participant retention, 2) social anxiety, 3) depression, and 4) self-compassion.
Hypothesis 2c (Cultivating community): Compared to the exposure-only condition, reliable change magnitudes will be higher within the peer and compassion-enhanced conditions, with additive effects for the fully enhanced condition, on measures of 1) stigma and 2) sense of belonging.
Hypothesis 2d (Barriers to access and engagement): Compared to the exposure only condition, reliable change magnitudes will be higher in the peer and compassion-enhanced conditions, with additive effects for the fully enhanced condition, on measures of 1) enjoyableness, 2) likelihood to recommend, and 3) readiness and willingness to engage in therapy. Across conditions, participants will indicate a preference for peer co-facilitators over mental health providers only.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Factorial
- Masking
- Single blind (participant)
- Number of arms
- 4
- Model description
- This trial uses a 2-variable full factorial design within the Multiphase Optimization Strategy (MOST) framework. Participants will be assigned to one of four study conditions involving 5.5-7.5-hours of workshops (depending on study condition) conducted over 3 in-person group sessions. Study conditions will vary depending on whether they 1) include self-compassion (i.e., common humanity) enhancements, and 2) are led by peer co-facilitators.
| Arm | Type | Receives |
|---|---|---|
| Exposure Only | Active comparator | Behavioral: Group Exposure for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears. |
| Compassion Enhanced | Experimental | Behavioral: Self-Compassion Enhanced Group Exposure Therapy for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears plus self-compassion exercises aimed at inducing a sense of common humanity. |
| Peer enhanced | Experimental | Behavioral: Peer-Enhanced Group Exposure Therapy for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears facilitated by a pair of doctoral student and undergraduate student co-facilitators who will explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears. |
| Fully enhanced | Experimental | Behavioral: Peer and Self-Compassion Enhanced Group Exposure Therapy for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears plus self-compassion exercises aimed at inducing a sense of common humanity, facilitated by a pair of doctoral student and undergraduate student co-facilitators who will explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (8 listed)
- Age = 18-30
- Able to read and write fluently in English
- Current undergraduate students at CU
- Experiencing elevated social anxiety symptoms indicated by a SPIN score ≥ 19
- Experiencing moderate to high communication anxiety indicated by a PRCA- 24 score ≥ 59
Key exclusion criteria (3 listed)
- Are currently experiencing moderately severe or severe depression represented by the validated cutoff score for major depression on the PHQ-8 of greater than 14 (Kroenke et al., 2001)
- Score in the moderate-high range for suicide risk as indicated by the CSSRS (Salvi, 2019), report a suicide attempt in the past 12 months, or report current, ongoing suicidal ideation along with a past (lifetime) suicide attempt
- Are current students of the PI or clients or current students of the doctoral student co-facilitators
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Group Exposure for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears. | Behavioural | Exposure Only |
| Self-Compassion Enhanced Group Exposure Therapy for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears plus piloted exercises from the investigators' previous studies among socially anxious undergraduates (Slivjak et al., 2022; Slivjak \& Arch, in preparation), refined during the investigators' quality improvement project, that are designed to enhance compassion. | Behavioural | Compassion Enhanced |
| Peer-Enhanced Group Exposure Therapy for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears facilitated by a pair of doctoral student and undergraduate student co-facilitators who explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears. | Behavioural | Peer enhanced |
| Peer and Self-Compassion Enhanced Group Exposure Therapy for Social AnxietyGroup exposure therapy for social anxiety and public speaking fears plus piloted exercises from the investigators' previous studies among socially anxious undergraduates (Slivjak et al., 2022; Slivjak \& Arch, in preparation), refined during the investigators' quality improvement project, that are designed to enhance compassion. These groups are facilitated by a pair of doctoral student and undergraduate student co-facilitators who explicitly use appropriate self-disclosure to establish the co-facilitators as individuals with lived experiences of social anxiety and public speaking fears. | Behavioural | Fully enhanced |
Primary outcome
Attendance rate
Time frame: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Average number of workshop sessions attended by enrolled research participants.
Enrollment rate
Time frame: Pre-intervention (from screening to enrollment)
Ratio of screened, eligible participants who enrolled in the study.
Acceptability of Intervention Measure (AIM)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Workshop satisfaction rating, Range = 1 - 5, Higher scores indicate better outcome (greater acceptability)
Client Satisfaction Questionnaire-8 (CSQ-8)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Satisfaction with workshops, Range = 8 - 32, Higher scores indicate better outcome (greater satisfaction)
Social Phobia Inventory (SPIN)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Social anxiety symptom measure, Range = 0 - 68, Higher scores indicate worse outcome (worse social phobia)
Liebowitz Social Anxiety Scale (LSAS)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Measure assessing fear/anxiety across a broad range of social and performance situations, Range = 0 - 144, Higher scores indicate worse outcome (worse social anxiety)
13 secondary outcomes
Personal Report of Communication Apprehension (PRCA-24)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Fidelity
Time frame: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Contamination
Time frame: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Study Burden
Time frame: 48 hours after the final intervention session and 1-month follow-up
Survey Completion
Time frame: between 10 and 0 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up
Participant Retention
Time frame: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)
Patient Health Questionnaire-8 (PHQ-8)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Self-Compassion Scale - Short (SCS)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Stigma and Self-Stigma Scale, help seeking behaviors and self-stigma subscales (SASS)
Time frame: 48 hours after the final intervention session and 1-month follow-up
Sense of Belonging Scale
Time frame: 48 hours after the final intervention session and 1-month follow-up
Likelihood to Recommend
Time frame: 48 hours after the final intervention session and 1-month follow-up
Enjoyableness
Time frame: 48 hours after the final intervention session and 1-month follow-up
Provider preference
Time frame: between 0 and 10 days before the first intervention session, 48 hours after the final intervention session, and 1-month follow-up
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 20 May 2025.
- Individual participant dataSharing planned: No
Related trials for Social Anxiety Disorder
Not yet recruiting
Preventive and Personalized Digital Emotion Regulation Skills Intervention to Reduce Depression and Anxiety in Youths With Adverse Childhood Experiences
Adverse Childhood Experience, Depression / Major Depressive Disorder
Recruiting
Bonding Before Birth: A mHealth Intervention for First-time Expectant Couples
Anxiety, Pregnancy
Recruiting
Comprehensive Assessment of Rehabilitation Experience Using the SAFE Scale
Caregiver Anxiety, Acquired Brain Injury
Not yet recruiting
Online Study on the Impact of a Self-Help Tool for Social Anxiety
Social Anxiety
Active, not recruiting
Targeting Social Function in Anxiety and Eating Disorders
Eating Disorders, Anorexia Nervosa
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Group Exposure for Social Anxiety, Self-Compassion Enhanced Group Exposure Therapy for Social Anxiety and Peer-Enhanced Group Exposure Therapy for Social Anxiety in people with Social Anxiety Disorder and Public Speaking Fear, run by University of Colorado, Boulder at 1 site in United States.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 20 May 2025. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Joanna Arch, PhD (303.492.4634, joanna.arch@colorado.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Attendance rate (time frame: 3 weeks during the intervention (workshops 1, 2, and 3, 1 week apart)). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 May 2025.